AI
Alfonso Iorio
McMaster University, University of Perugia
Research areas: Medicine · Hematology · Hemophilia Treatment and Research · Platelet Disorders and Treatments · Blood Coagulation and Thrombosis Mechanisms
0000-0002-3331-8766
Employment
-
McMaster University Professor2017 - Present
-
McMaster University Associate Professor2010 - 2017
-
University of Perugia Assistant Professor2001 - Present
Education
- 2009 - 2012
-
University of Perugia Fellowship in Internal Medicine2001 - 2006
-
University of Perugia Fellowship in Clinical Chemistry and Biochemistry1992 - 1996
- 1984 - 1991
Projects & Funding
Projects & funding information is unavailable.
Publications (472)
- Attitudes and perceptions toward the use of artificial intelligence chatbots for peer review in medical journals: a large-scale, international cross-sectional survey Save
- Long-term experience with emicizumab in people with hemophilia A in the Canadian Bleeding Disorders Registry Save
- Understanding Transformer-Based Classifications of Medical Text Using a Large Language Model for the Attribution of Feature Importance: Proof-of-Concept Algorithm Development and Validation Study Save
- A case report of high-titer FVIII inhibitor development after AAV-mediated gene therapy in hemophilia A Save
- What You May Have Missed in 2025 Save
- Fine-Tuning and Benchmarking Transformer Models for Multiclass Classification of Clinical Research Papers: Retrospective Modeling Study Save
- Attitudes and Perceptions Toward the Use of Artificial Intelligence Chatbots for Peer Review in Medical Journals: A Large-Scale, International Cross-Sectional Survey Save
- Attitudes of medical and life sciences university students and postdoctoral fellows toward AI chatbots in education: an international cross-sectional survey Save
- Zero-shot interpretable biomedical literature appraisal with generative large language models Save
- Evaluation of the Burden of Bone Fractures in People Living With Haemophilia: A Registry‐Based Matched Cohort Study Save
- Comparative safety of drug therapies used in hemophilia A and B in Canada: a multi-center, retrospective study Save
- Core GRADE unpacked: a summary of recent innovations in complementary GRADE methodology Save
- Country-level prediction of blood type distribution in hemophilia A in support of factor VIII consumption Save
- GRADE Guidance: Update on Developing Good Practice Statements in Guidelines Save
- Risk Factors for the Development of Food Allergy in Infants and Children A Systematic Review and Meta-Analysis Save
- The WFH Guidelines for the Management of Haemophilia: AAV Gene Therapy, 2025 Save
- florio HAEMO-A Digital Medical Device for Monitoring of Treatment, Symptoms and Physical Activities for People Living With Haemophilia Save
- Canadian Clinical Experience on Switching From Standard Half‐life Recombinant Factor VIII (rFVIII), Octocog Alfa, to Extended Half‐life rFVIII, Damoctocog Alfa Pegol, in Persons With Haemophilia A ≥ 12 Years Followed in a Comprehensive Haemophilia Care P… Save
- Feasibility of Administering the Patient Reported Outcomes, Burdens and Experiences (PROBE) Questionnaire Through the Canadian Bleeding Disorders Registry (CBDR) and Comparison of Data From the Two Sources Save
- Attitudes and perceptions towards the use of artificial intelligence chatbots in medical journal peer review: A protocol for a large-scale, international cross-sectional survey Save